VIC Researcher Looks into Using Psychedelics to Combat Intergenerational Trauma
A growing body of scientific literature has revealed that psychedelic drugs such as ketamine, MDMA and psilocybin may have therapeutic potential. Researchers have found in recent years that these hallucinogens may be able to alleviate the symptoms of certain mental health disorders when accompanied by talk therapy. Furthermore, psychedelics seem to deliver these mental health benefits after relatively little doses and with few side effects. Major investors including pharmaceutical companies are now investing millions of dollars into psychedelic research to be the first to develop psychedelic-based treatments. According to Vancouver Island University researchers, tapping into indigenous knowledge will be key…